blog
English
Home
Products
Biological Raw Materials Lateral Flow Immunoassay Molecular Diagnostics
Infectious Diseases
Drugs of Abuse
Hormones
Tumor Markers
Cardiac Markers
Inflammation
Serum Proteins
Food Safety
Others
PCR reagent
Animal Disease
Thrombus
Infectious Disease
Drug of Abuse
Fertility
Tumor Markers
Cardiac Marker
Inflammation
Veterinary
Respiratory Tract Infections
Sexually Transmitted Infection
Zoonosis
COVID-19
Antigen Detection Antibody Detection Nucleic Acid Test Specimen Collection
Download
Download
News
Company News Statement Marketing Activities
About us
About Clongene Product Platform Strengths and Mission Milestone Company Strength and Honor
Contact
Contact Us
  • All
  • Products
  • News
  • Manuals
  • Instruments
    • Company News
    Company News Statement Marketing Activities
    Company News
    2024.11.09

    Congratulations！Clongene Fentanyl Rapid Test Kit Receives FDA 510(k) Approval

    On November 8, 2024, Clongene independently developed the Fentanyl Rapid Test Kit, which received FDA 510(k) approval and can meet the testing needs of home and professional institutions. The product
    More
    2022.04.27

    Clungene COVID-19 Antigen Rapid Test Products Obtained TGA Certification in Australia

    “Clungene COVID-19 Antigen Rapid Test for self-testing” and “Clungene COVID-19 Antigen Rapid Test” manufactured by Clongene have obtained the TGA Certification in Australia on January 7, 2022. The cer
    More
    2022.04.27

    Clungene COVID-19 Antigen Rapid Test has obtained CE certification

    In February 2022, CLUNGENE® COVID-19 Antigen Rapid Test for self-testing manufactured by Clongene has obtained the CE certification in EU. Our self-testing product can be sold in the European Union an
    More
    2022.04.27

    CLUNGENE® COVID-19 Antigen Rapid Test Cassette Passed the PEI Test in Germany

    CLUNGENE® COVID-19 Antigen Rapid Test Cassette has passed the test of PEI in Germany. PEI (Paul-Ehrlich-Institut) is affiliated to the Federal Ministry of Health. It is the Cooperation Centre of WHO f
    More
    2022.08.18

    Congratulations! Clongene COVID-19 Antigen Rapid Tests have passed SARS-CoV-2 variants validation by TGA

    The TGA is reviewing all COVID-19-specific laboratory antigen tests and rapid antigen tests (RATs), including point-of-care and self-tests, included in the Australian Register of Therapeutic Goods (AR
    More
    7 Total